Advertisement
Research Article| Volume 1, ISSUE 1, P21-37, March 1981

Assessing the Clinical Utility of Laboratory Methods

  • M. Desmond Burke
    Correspondence
    Mount Sinai Hospital, 2215 Park Avenue, Minneapolis, Minnesota 55404.
    Affiliations
    Associate Pathologist, Mount Sinai Hospital, Minneapolis

    Associate Professor, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)31114-4
Assessing the Clinical Utility of Laboratory Methods
Previous ArticleTechnology Assessment in Laboratory Medicine: Rationalizing or Rationing?
Next ArticleEconomic Analysis in Assessing Technology in Clinical Laboratories
      This paper is only available as a PDF. To read, Please Download here.
      A clinically useful test is one that, indirectly, leads to better management results. Decision analysis and benefit-risk models are discussed as means by which performance standards can be set to determine when to treat or not to treat a patient. The difficulties involved in such an assessment are probed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Analytical goals in clinical chemistry
        Their relationship to medical care. Proceedings of the Subcommittee on Analytical Goals in Clinical Chemistry, WASP, CIBA Foundation, London, 1978.
        Am. J. Clin. Pathol. 1979; 71: 624-630
        • Baden H.
        • Anderson B.
        • Augustenburg G.
        • et al.
        Diagnostic value of gamma-glutamyl transpeptidase and alkaline phosphatase in liver metastases.
        Surg. Gynecol. Obstet. 1971; 133: 769-773
        • Barnett R.N.
        Medical significance of laboratory results.
        Am. J. Clin. Pathol. 1968; 50: 671-676
        • Barrett A.E.
        • Cameron S.J.
        • Fraser C.G.
        • et al.
        A clinical view of analytical goals in clinical biochemistry.
        J. Clin. Pathol. 1979; 32: 893-896
        • Benson E.S.
        Initiatives toward effective decision making and laboratory use.
        Human Pathol. 1980; 11: 440-448
        • Blomberg D.J.
        • Kimber W.D.
        • Burke M.D.
        Creatine kinase isoenzymes: predictive value in the early diagnosis of acute myocardial infarction.
        Am. J. Med. 1975; 59: 464-469
        • Burke M.D.
        Clinical decision-making: The role of the laboratory.
        in: Benson E.S. Rubin M. Logic and Economics of Laboratory Use. Elsevier North-Holland, Inc., New York1978: 59-64
        • Campbell E.J.M.
        Basic science, science, and medical education.
        Lancet. 1976; 1: 134-136
        • Casscells W.
        • Schoenberger A.
        • Graboys T.B.
        Interpretation by physicians of clinical laboratory results.
        N. Engl. J. Med. 1978; 299: 999-1001
        • College of American Pathologists
        Goals in Clinical Chemistry: Proceedings of the 2nd Annual Aspen Conference. Aspen, Colorado1976: 4
        • Cotlove E.
        • Harris E.K.
        • Williams G.Z.
        Biological and analytical components of variation in long-term studies of serum constituents in normal subjects. III. Physiological and medical implications.
        Clin. Chem. 1970; 16: 1028-1032
      12. Diagnostic testing (editorial).
        Lancet. 1979; 2: 809-810
        • Elstein A.S.
        • Shulman L.S.
        • Sprafka S.A.
        Medical Problem Solving: An Analysis of Clinical Reasoning. Harvard University Press, Cambridge1978
        • Fraser C.G.
        Analytical goals in clinical biochemistry.
        in: Stefanini M. Benson E.S. Progress in Clinical Pathology, Vol. VIII. Grune and Stratton, Inc., New York1981 (in press)
        • Galen R.S.
        • Gambino S.R.
        Beyond Normality: The Predictive Value and Efficiency of Medical Diagnosis. Wiley, New York1975
        • Galen R.S.
        • Reiffel J.A.
        • Gambino S.R.
        Diagnosis of acute myocardial infarction: relative efficiency of serum enzyme and isoenzyme measurements.
        J.A.M.A. 1975; 232: 145-147
        • Gilbert R.K.
        Progress and analytical goals in clinical chemistry.
        Am. J. Clin. Pathol. 1975; 63: 900-973
        • Gorry G.A.
        • Kassirer J.P.
        • Essig A.
        • et al.
        Decision analysis as the basis for computer-aided management of acute renal failure.
        Am. J. Med. 1973; 55: 473-484
        • Homburger H.A.
        • Hewan-Lowe K.
        Predictive value of thyroxine, thyrotropin and triiodothyronine concentrations in serum.
        Clin. Chem. 1979; 25: 669-674
        • Ingelfinger F.J.
        Decision in medicine.
        N. Engl. J. Med. 1975; 293: 254-255
      21. International Federation of Clinical Chemistry. Provisional recommendation on quality control in clinical chemistry. Part 6. Quality requirements from the point of view of health care.
        Clin. Chim. Acta. 1977; 74: F1-F6
        • Kassirer J.P.
        • Gorry J.A.
        Clinical problem solving: A behavioral analysis.
        Ann. Intern. Med. 1976; 89: 245-255
        • Leaper D.J.
        • Gill P.W.
        • Staniland L.R.
        Clinical diagnostic process: an analysis.
        Br. Med. J. 1973; 2: 569-574
        • Maloney T.W.
        • Rogers D.E.
        Medical technology—a different view of the contentious debate over costs.
        N. Engl. J. Med. 1979; 301: 1413-1419
        • Medawar P.B.
        Induction and Intuition in Scientific Thought. Methuen, London1969
        • McNeil B.J.
        • Adelstein S.J.
        Measures of clinical efficacy: the value of case-finding in hypotensive renovascular disease.
        N. Engl. J. Med. 1975; 293: 221-226
        • McNeil B.J.
        • Keeler E.
        • Adelstein S.J.
        Primer on certain elements of medical decision making.
        N. Engl. J. Med. 1975; 293: 211-215
        • McNeil B.J.
        • Varady P.D.
        • Burrows B.A.
        • et al.
        Cost-effectiveness in hypertensive renovascular disease.
        N. Engl. J. Med. 1975; 293: 216-221
        • Pauker S.G.
        Coronary artery surgery: The use of decision analysis.
        Ann. Intern. Med. 1976; 85: 8-18
        • Pauker S.G.
        • Kassirer J.P.
        Therapeutic decision-making: A cost-benefit analysis.
        N. Engl. J. Med. 1975; 293: 229-234
        • Pauker S.G.
        • Kassirer J.P.
        The threshold approach to clinical decision making.
        N. Engl. J. Med. 1980; 302: 1109-1117
        • Pilowsky I.
        • Durbridge T.C.
        The diagnostic utility index.
        Med. Educ. 1979; 13: 425-427
        • Raine D.N.
        Screening for disease: inherited metabolic disease.
        Lancet. 1974; 2: 996-998
        • Ransohoff D.F.
        • Feinstein A.R.
        Is decision analysis useful in clinical medicine? Yale J.
        Biol. Med. 1976; 49: 165-168
        • Ransohoff D.F.
        • Feinstein A.R.
        Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.
        N. Engl. J. Med. 1978; 229: 926-930
        • Ross J.W.
        • Fraser M.D.
        Analytical clinical chemistry precision. State of the art for fourteen analytes.
        Am. J. Clin. Pathol. 1977; 68: 130-141
        • Sackett D.
        • Holland W.W.
        Controversy in the detection of disease.
        Lancet. 1975; 2: 357-359
        • Safran C.
        • Desforges J.F.
        • Tsichlis P.N.
        • et al.
        Decision analysis to evaluate lymphangiogra phy in the management of patients with Hodgkin’s disease.
        N. Engl. J. Med. 1977; 296: 1088
        • Schwartz W.B.
        Decision analysis: a look at the chief complaints.
        N. Engl. J. Med. 1979; 300: 556-559
        • Schwartz W.B.
        • Gorry G.A.
        • Kassirer J.P.
        • et al.
        Decision analysis and clinical judgment.
        Am. J. Med. 1973; 55: 459-472
        • Sunderman Jr., F.W.
        Current concepts of “normal values”, “reference values”, and “discrimination values” in clinical chemistry.
        Clin. Chem. 1975; 21: 1873-1877
        • Tonks D.B.
        A study of the accuracy and precision of clinical chemistry determinations in 170 Canadian laboratories.
        Clin. Chem. 1963; 9: 217-223
        • Tversky A.
        • Kahneman D.
        Availability: A heuristic forjudging frequency and probability.
        Cognitive Psychol. 1973; 5: 207-232
        • Vecchio T.J.
        Predictive value of a single diagnostic test in unselected populations.
        N. Engl. J. Med. 1976; 274: 1171-1173
        • Weinstein M.C.
        • Fineberg H.V.
        Cost-effectiveness analysis for medical practices: Appropriate laboratory utilization.
        in: Benson E.S. Rubin M. Logic and Economics of Clinical Laboratory Use. Elsevier, North-Holland, Inc., New York1978
        • Weinstein M.C.
        • Stason W.B.
        Foundations of cost-effectiveness analysis for health and medical practices.
        N. Engl. J. Med. 1977; 296: 716-721
        • Werner M.
        • Altshuler C.H.
        Utility of multiphasic biochemical screening and systematic laboratory investigations.
        Clin. Chem. 1979; 25: 509-511
        • Werner M.
        • Brooks S.H.
        • Wette R.
        Strategy for cost-effective laboratory testing.
        Hum. Pathol. 1973; 4: 17-30
        • Wertman B.G.
        • Sostrin S.V.
        • Pavlova Z.
        • et al.
        Why do physicians order laboratory tests: A study of laboratory test request and use patterns.
        J.A.M.A. 1980; 243: 2080-2082
        • Whitby L.G.
        Screening for disease: Definitions and criteria.
        Lancet. 1974; 2: 819-822
        • Yerushalmy J.
        Statistical problems in assessing methods of medical diagnosis, with special reference to x-ray techniques.
        Public Health Rep. 1947; 62: 1432-1449

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)31114-4

      Copyright

      © 1981 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX